http://online.wsj.com/article/PR-CO-20140529-906827.html
StemCells, Inc. Posts Letter to Shareholders NEWARK, Calif., May 29, 2014 (GLOBE NEWSWIRE) — StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system, posted today the following Letter to Shareholders from its President and CEO, Martin McGlynn. Dear Fellow Shareholders…